Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · IEX Real-Time Price · USD
0.713
+0.033 (4.91%)
At close: May 3, 2024, 4:00 PM
0.700
-0.013 (-1.86%)
After-hours: May 3, 2024, 7:56 PM EDT

Petros Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
5354443-
Market Cap Growth
--35.68%-88.98%1.88%--
Enterprise Value
-0-25203312
PE Ratio
-0.22-0.22-0.24-4.87-2.09-
PS Ratio
0.840.530.815.614.50-
PB Ratio
0.410.260.291.232.46-
P/FCF Ratio
-0.41-0.41-0.38-3.69-2.81-
P/OCF Ratio
-0.41-0.41-0.38-3.69-2.81-
EV/Sales Ratio
-0.38-0.380.812.553.450.74
EV/EBITDA Ratio
0.530.53-0.36-12.19-2.70-0.83
EV/EBIT Ratio
0.290.29-0.25-2.31-1.74-0.60
EV/FCF Ratio
0.290.29-0.38-1.68-2.164.71
Debt / Equity Ratio
0.660.660.57-0.411.71
Debt / EBITDA Ratio
-1.90-1.90-0.69--0.59-0.98
Debt / FCF Ratio
-1.05-1.05-0.74--0.475.58
Quick Ratio
1.441.441.630.850.530.12
Current Ratio
1.891.892.080.990.620.29
Asset Turnover
0.180.180.140.130.150.25
Interest Coverage
-14.23-14.23-32.62-23.38-6.22-1.39
Return on Equity (ROE)
-116.60%-116.60%-74.70%-38.30%-161.50%-1025.90%
Return on Assets (ROA)
-41.90%-41.90%-45.30%-14.80%-32.10%-51.90%
Return on Capital (ROIC)
-53.58%-53.58%-76.07%-50.78%-70.13%-88.74%
Earnings Yield
-281.67%-445.12%-415.29%-20.52%-47.90%-
FCF Yield
-155.50%-245.74%-265.23%-27.09%-35.62%-
Buyback Yield / Dilution
-5.11%-5.11%-90.11%-103.90%-117.10%-
Total Shareholder Return
-5.11%-5.11%-90.11%-103.90%-117.10%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).